why choose us

First received: September 16, 2024

Clinical Trial: A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Plaque Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study of LY4100511 (DC-853) for the Treatment of Adult Participants With Moderate-to Severe Plaque Ps

Brief Summary: The main purpose of this study is to assess the safety and efficacy of LY4100511 in adult participants with moderate-to-severe plaque psoriasis.

Read more